Ticker Scorecard - ALDX Basics Company: Aldeyra Therapeutics, Inc. IPO Date: April 28, 2014 Sector: Healthcare Industry: Biotech Market Cap: $318.59M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 3.27% Avg Daily Range (30 D): $0.13 | 2.51% Avg Daily Range (90 D): $0.13 | 2.55% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .37M Trade Size Avg Trade Size (Sh.): 142 Avg Trade Size (Sh.) (30 D): 85 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 421 Avg Inst. Trade: $1.74M Avg Inst. Trade (30 D): $3.54M Avg Inst. Trade (90 D): $2.07M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.91M Avg Closing Trade (30 D): $3.54M Avg Closing Trade (90 D): $2.07M Avg Closing Volume: 251.77K     News Jun 2, 2024 @ 10:49 AM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast May 14, 2024 @ 1:40 PM Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its... Source: Zacks Equity Research Apr 22, 2024 @ 1:40 PM Is Aldeyra Therapeutics (ALDX) Outperforming Other... Source: Zacks Equity Research Apr 6, 2024 @ 10:37 AM Aldeyra (ALDX) Stock Rallies 43% in One Week: Here... Source: Zacks Equity Research Apr 5, 2024 @ 1:40 PM Are Medical Stocks Lagging Aclaris Therapeutics (... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.75 $-.25 $-.28 Diluted EPS $-.75 $-.25 $-.28 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -44.8M $ -15.11M $ -16.85M Operating Income / Loss $ -49.64M $ -16.14M $ -18.01M Cost of Revenue $ $ $ Net Cash Flow $ -75.21M $ -2.91M $ -31.46M PE Ratio